Evidence map›Paper›PMID 38596440›Full record

ArticleWorld journal of clinical pediatrics2024

Inpatient management of iron deficiency anemia in pediatric patients with inflammatory bowel disease: A single center experience.

Krishanth Manokaran, Jonathan Spaan, Giulio Cataldo, Christopher Lyons, Paul D Mitchell, Tatyana Sare, Lori A Zimmerman, Paul A Rufo

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of clinical pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Krishanth ManokaranCenter for Inflammatory Bowel Disease, Boston Children's Hospital, Boston, MA 02115, United States.
Jonathan SpaanCenter for Inflammatory Bowel Disease, Boston Children's Hospital, Boston, MA 02115, United States.
Giulio CataldoCenter for Inflammatory Bowel Disease, Boston Children's Hospital, Boston, MA 02115, United States.
Christopher LyonsCenter for Inflammatory Bowel Disease, Boston Children's Hospital, Boston, MA 02115, United States.
Paul D MitchellInstitutional Centers for Clinical and Translational Research, Boston Children's Hospital, Boston, MA 02115, United States.
Tatyana SareCenter for Inflammatory Bowel Disease, Boston Children's Hospital, Boston, MA 02115, United States.
Lori A ZimmermanCenter for Inflammatory Bowel Disease, Boston Children's Hospital, Boston, MA 02115, United States.
Paul A RufoCenter for Inflammatory Bowel Disease, Boston Children's Hospital, Boston, MA 02115, United States. paul.rufo@childrens.harvard.edu.
Boston Children's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundScreening for iron deficiency anemia (IDA) is important in managing pediatric patients with inflammatory bowel disease (IBD). Concerns related to adverse reactions may contribute to a reluctance to prescribe intravenous (IV) iron to treat IDA in this population.

aimTo track the efficacy and safety of IV iron therapy in treating IDA in pediatric IBD patients admitted to our center.

methodsA longitudinal observational cohort study was performed on 236 consecutive pediatric patients admitted to our tertiary IBD care center between September 2017 and December 2019. 92 patients met study criteria for IDA, of which 57 received IV iron, 17 received oral iron, and 18 were discharged prior to receiving iron therapy.

resultsPatients treated with IV iron during their hospitalization experienced a significant increase of 1.9 (± 0.2) g/dL in mean (± SE) hemoglobin (Hb) concentration by the first ambulatory follow-up, compared to patients who received oral iron 0.8 (± 0.3) g/dL or no iron 0.8 (± 0.3) g/dL (

conclusionOur findings demonstrate that treatment with IV iron therapy is safe and efficacious in improving Hb and iron levels in pediatric patients with IDA and active IBD.

Indexed as

Inflammatory bowel diseaseIntravenous iron therapyIron deficiency anemiaPediatric inflammatory bowel disease

Identifiers

PMID38596440
PMCPMC11000066
OpenAlexW4392500706

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.